Oxon Hill, MD, United States of America

Ivan O Edafiogho


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Oxon, MD (US) (1995)
  • Oxon Hill, MD (US) (1996 - 1997)

Company Filing History:


Years Active: 1995-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Ivan O. Edafiogho: Pioneering Pharmaceutical Innovations

Introduction

Ivan O. Edafiogho, an inventor based in Oxon Hill, Maryland, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, his inventions demonstrate a robust commitment to advancing medicinal chemistry and related applications.

Latest Patents

Among his latest innovations are the patents for Enaminone Esters and Isoxazolyl Enaminones. The Enaminone Esters patent describes compounds characterized by the formula involving specific radical substitutions, including a methoxy group and various phenyl groups. The Isoxazolyl Enaminones patent presents a novel oxazolyl enaminone with distinct structural properties and potential applications in pharmaceuticals, including acceptable salts and isomers for therapeutic use.

Career Highlights

Ivan O. Edafiogho is currently affiliated with Howard University, where he leverages his expertise in medicinal chemistry to foster innovation and research in pharmaceutical sciences. His work contributes to the development of new drug candidates with enhanced efficacy and safety profiles, indicating a strong passion for addressing unmet medical needs.

Collaborations

Throughout his career, Ivan has worked alongside esteemed colleagues such as Kenneth R. Scott and Jesse M. Nicholson. Together, they have contributed to various research initiatives, further enhancing the collaborative research environment at Howard University.

Conclusion

Ivan O. Edafiogho is a noteworthy figure in medicinal chemistry, with a focus on developing innovative pharmaceutical solutions. His patents not only underscore his inventive spirit but also his dedication to improving healthcare outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…